Health encyclopaedia - Alphabetical Topic List

| A | | B | | C | | D | | E | | F | | G | | H | | I | | J | | K | | L | | M |
| N | | O | | P | | Q | | R | | S | | T | | U | | V | | W | | X | | Y |

Treatment of Motor neurone disease

The National Institute for Clinical Excellence (NICE) has approved the drug, Riluzole (Rilutek) for patients with ALS, the most common form of the disease. Rilutek can slow progress of the condition and enables individuals to remain longer in the earlier stages of the disease when symptoms are least severe.

There is no known cure for motor neurone disease. Depending on the part of the body first affected, the survival time varies from two to ten years with some people surviving for more than 20 years.

Support groups can be very important in helping people with MND and their families to cope as the disease progresses.